“Right now, the throughput for cell and gene therapies is limited. We don’t fully understand how to manufacture therapies in a reproducible manner, from scaling up and scaling out. This type of facility will hopefully …

“This is a complete game-changer for New Jersey. BioCentriq is a state-of-the-art facility that will attract cutting-edge companies and innovation from around the world.”

Developing and manufacturing cell and gene therapies consistently, efficiently and at-scale has not only slowed their market entry but also has resulted in costs that are too prohibitive for most patients — but the team …

NJII has made significant progress in the area of regenerative medicine and we are very excited about their new center and the opportunity for companies of varying sizes to leverage the center for cell and …

The pace of development in cell and gene therapy is unprecedented in the biopharmaceutical industry. Our team of indication agnostic industry experts and cutting edge development center are uniquely equipped to help the industry advance …

Folks are beginning to understand the value of having their health information available to any doctor who needs to see them, without resorting to outdated methods like paper mail and fax. Interoperability and data integration-including …